Correlate’s strategic investments in clean electrification solutions and commercial solar infrastructure have earned the company a growing customer base, and…
Odyssey acquired IP and all rights to PRV-002, its lead drug candidate for the treatment of concussions, on March 1,…
The IEA sees EV sales hitting a record in 2022 after doubling in 2021 from 2020, while noting the lack…
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed an innovative platform for heart attack detection anytime, anywhere, was…
Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is currently conducting a potentially pivotal global phase 2 clinical trial in humans…
Odyssey Health (OTC: ODYY) early last year acquired PRV-002, a drug candidate for concussed patients to mitigate both short-term and…
LQwD is focused on creating enterprise-grade infrastructure to drive bitcoin adoption and, develop institutional-grad services supporting the Lightning Network functionality,…
Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, announced that LidarSwiss Solutions GmbH is deploying…
Data Protection has increasingly become a focus around the globe, with the United States and Europe recently agreeing to implement…